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Abstract 
Background: To secure the gains of lymphatic filariasis (LF) elimination programs, attention is needed to the ‘residual 
microfilaremia phase’, in which high-risk populations may be crucial. The present study documents the impact of mass 
drug administration (MDA) in the urban Indian setting of Surat City, with high rates of in-migration.
Methods: Epidemiological assessment included National Filaria Control Program (NFCP) and World Health Organiza-
tion recommended routine and pre-MDA microfilaremia surveys respectively. Routine filaria surveys were conducted 
around the year in approximately 2000–4000 people per month, while pre-MDA surveys were carried out annually 
among approximately 4000 people from four fixed and four random sites. In 2016, Transmission Assessment Survey 
(TAS) was done in primary school children. The outcomes were microfilaremia (Mf ) and antigen prevalence; more spe-
cifically, microfilaremia according to place of birth, in pre-MDA and routine night blood smears (NBS) collected from 
2008 to 2015. Prevalence ratios and confidence intervals were calculated.
Results: A total of 25 480 pre-MDA and 306 198 routine NBS were examined during the study. In 2008, the Mf preva-
lence in the routine survey was 63/18 814 (0.33%), declining to 23/39 717 (0.06%) in 2016. Pre-MDA surveys showed 
a similar decrease from 47/4184 (1.1%) in 2008 to 12/4042 (0.3%) in 2015. In those born outside Surat, microfilaremia 
decreased below transmission thresholds, but remained more than treble that of the remainder of the population, 
in both the pre-MDA surveys [prevalence ratio: 3.17, 95% confidence interval (CI): 1.15–8.72], and the routine surveys 
(3.31, 95% CI: 1.47–7.48). Though the TAS results indicated that MDA endpoints had been reached, sub-group analysis 
identified that 90% of antigenemic children were from families of high-risk groups.
Conclusions: Extensive long-term epidemiological monitoring suggests that all the urban population, including 
high-risk groups, have benefitted from the ELF program. To prevent re-establishment of infection in large urban areas 
with unsanitary conditions conducive to filarial vector breeding, there is need to identify residual microfilaremia by 
customized surveys in addition to pre-MDA monitoring and TAS. The present findings can be used to develop strate-
gies to prioritize screening, surveillance and plan treatment of high-risk groups after achieving MDA endpoints.
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Elimination, Residual microfilaremia
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Background
The rapid pace of unplanned urbanization and the 
lack of proper sanitary conditions in many cities in 
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developing nations enhance the transmission of vector-
borne diseases  [1–3]. Among these, lymphatic filaria-
sis (LF) is primarily a neglected tropical disease of the 
poor in disadvantaged peri-urban, urban, and rural 
areas, causing damage of the lymphatic system leading 
to long term disfigurement and disability [3].
In May 1997, the World Health Assembly passed a 
resolution making elimination of lymphatic filaria-
sis (ELF) a public health priority. The global program 
for ELF (GPELF) depends primarily on mass drug 
administration (MDA), integrated vector management 
(IVM), morbidity management and disability preven-
tion (MMDP) [4, 5]. Since 2000, administration of more 
than 8.2 billion cumulative treatments to approximately 
923 million people has helped achieve 43% reduc-
tion in the total population endemic for filariasis  [6]. 
Currently, 17 out of the 72 endemic countries with 
on-going transmission of the mosquito-borne filarial 
parasites (Wuchereria bancrofti, Brugia malayi and B. 
timori) [6, 7] have been validated for elimination of LF, 
while five countries have stopped MDA and are now 
under surveillance. India has about 40% of the global 
filariasis burden and 50% of the global population at 
risk of infection  [8]. Culex quinquefasciatus mosqui-
toes are the principal vectors of LF in India [3, 9].
Considering the huge resources required to provide 
MDA; programme monitoring, surveillance and evalu-
ation are essential to determine when endpoints have 
been attained or, conversely, to identify populations and 
areas requiring renewed efforts [10, 11]. This involves 
measurement of circulating filarial antigen (CFA) in the 
human population via a standardized tool known as the 
Transmission Assessment Survey (TAS). India achieved 
effective coverage in 90% of the implementing units in 
2016, and MDA has been stopped in 94 of 256 endemic 
districts after passing TAS [7].
The gains achieved to date by ELF programs in India 
and the world are dependent on preventing the re-estab-
lishment of transmission [1, 12, 13]. Global research on 
urban filariasis is largely of short duration, concentrated 
in a few small areas [3, 12]; e.g. on India’s eastern coast, 
with little emphasis on identification of high-risk popu-
lations groups  [13, 14]. Available review and research 
articles on ELF and MDA have indicated the need to 
understand factors that may threaten to reestablish trans-
mission of lymphatic filariasis [1, 3, 14]. Rapid unplanned 
growth of urban cities and movement of rural popula-
tion to urban areas in search of jobs, also called internal 
migration  [15], poses one such challenge to coverage of 
mass drug treatment programs [1, 2]. Another problem is 
the co-existence of the parasite species W. bancrofti with 
the mosquito vector Cx. quinquefasciatus which thrives 
in unsanitary sewage and drainage conditions, which are 
common in overcrowded urban areas, home to poor peo-
ple without secure housing tenancy and who frequently 
need to move to pursue work  [3]. These populations 
often have an added disadvantage of reduced access to 
screening and treatment for filariasis unless programs are 
designed with them in mind [16].
With this background, the present study documents 
extensive microfilaremia monitoring and surveillance in 
humans over a decade and shows the impact of MDA 
on epidemiological indicators in a large urban setting on 
western coast in the developing country of India, with 
emphasis on identification of high-risk urban population 
groups. We envisage programmatic findings from our 
study will help to guide intervention strategies for main-
taining filariasis control in urban areas, especially those 




The National Filariasis Control Program (NFCP) for 
India started in the year 1955. On the basis of NFCP’s 
filariasis endemicity survey, urban Surat (Fig. 1), situated 
on the western coast of Gujarat state, was allotted one 
of 47 National Filaria Control Units (FCU) [17], and this 
unit implemented disease and vector surveillance accord-
ing to NFCP guidelines and recommendations[8, 18]. 
The NFCP was merged into the National Vector-Borne 
Disease Control program (NVBDCP) in 2003–2004. 
At present, Surat is a metropolitan city with 4.5 million 
inhabitants in an area of 326  km2.
As a signatory to WHA and GPELF, India started MDA 
in 1996–1997 in the form of a pilot project in Orissa state 
which was later expanded to country-wide endemic areas 
with the aim of eliminating filariasis by 2015[9, 11]. Guja-
rat state including Surat Municipal Corporation (SMC)—
the city’s administrative organization—launched MDA 
with diethylcarbamazine (DEC) and albendazole in 2004 
[9, 18, 19]. Surat City was considered as one implementa-
tion unit (IU) [4]. The peripheral health workers (PHWs) 
of the vector-borne disease control department (VBDC) 
of SMC conducted the ELF program activities under 
the supervision and guidance of full-time program and 
health officers. Twelve MDA rounds were carried out 
between 2004 and 2015. The process (coverage rates) and 
impact (Mf rate) indicators were monitored and reported 
every year following NVBDCP and WHO guidelines [4, 
18].
A previous independent assessment  [20] of MDA in 
endemic areas of Gujarat state including Surat Corpo-
ration found that coverage and compliance were ade-
quate in terms of WHO recommendations [4] and that 
microfilaremia rate had decreased by 70% in Surat City 
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between 2005 and 2015. Inbuilt program supervision 
indicates drug distribution above 95% and drug compli-
ance between 70 and 90% in different areas [19].
Study methods
Monitoring can be considered the component of surveil-
lance whose subject is proactive control measures. Here, 
the monitoring and evaluation (M&E) or pre-MDA sur-
veys were conducted as an annual activity for twelve years 
(2004–2015)  [18]. A total of 4000 NBS were collected 
from eight sites each year: 500 slides each from four sen-
tinel and four random/spot-check sites (Table  1)  [18]. 
The sentinel sites were identified from the list of city 
areas with highest microfilaremia and disease prevalence 
in the baseline survey of year 2004 while spot sites were 
randomly selected each year (2004–2015) from other 
city areas irrespective of microfilaremia (Mf) and disease 
prevalence [4, 20]. In this communication, we present the 
site-wise trend of Mf rate from year 2008 to 2015 after 
completion of four initial MDA rounds. This activity is 
considered adequate to assess the impact of the previ-
ous MDA rounds as the GPELF recommends periodic 
assessment in at least one sentinel site per one million 
Fig. 1 Map of Surat City, Gujarat, India. All LF surveys took place in the seven zones (32 units) shown by different colors on this map of Surat City /
Municipal Corporation (SMC). The red stars show the  sentinel sites having the highest prevalence of microfilaremia in pre-MDA baseline survey 
conducted in year 2004 (Table 1). From north to south, the sites are: (1) Utkal Nagar; (2) Ashok Nagar; (3A) Sub-jail; (4A) Tulsi Nagar; (4B) EWS quarters 
and (3B) Siddharth Nagar. Source: drawn by the authors on the basis of Google Maps depiction of Surat city
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population before (baseline), and then after third and 
fifth rounds of MDA [4].
NVBDCP/NFCP recommended preliminary surveys; 
control by both drug administration and vector man-
agement; and follow-up investigations. Adhering to 
the NFCP guidelines, Surat Filaria Control Unit (FCU) 
continued the epidemiological assessment of city popu-
lation by conducting microfilaremia and disease rate 
surveys every year since 1988  [17]. The present study 
shows the findings of NFCP/ routine surveys conducted 
between the years 2008–2015. For these surveys, multi-
stage random sampling was employed. Urban Surat was 
divided first into seven zones, then thirty-two units, fol-
lowed by hundred wards (Fig.  1). A list of all mohallas 
(small areas) and households was prepared at the ward 
level. One half of wards were selected at random, sub-
ject to no selected ward being selected again in the fol-
lowing three years. From the selected wards, one quarter 
of mohallas were randomly selected. From the list of 
households in the selected mohallas a random selection 
of 6–10% of the households, with a minimum of 14, was 
done per mohalla following national recommendations 
for conducting filaria survey [21, 22]. Daytime surveys of 
selected houses for filaria morbidity cases (lymphadeni-
tis, lymphangitis and elephantoid manifestations) were 
followed by night blood smear (NBS) collection from 
all family members of these houses from 9  pm to mid-
night[19, 20]. Approximately two to four thousand NBS 
were collected per month (seven teams in seven zones, 
times five field working days per week, times fifteen 
households per day).
In 2016, TAS was conducted when WHO and national 
criteria had been met: (1) five rounds of MDA with effec-
tive coverage > 65% had been carried out, and (2) the Mf 
prevalence of each additional site and pre-MDA spot 
and sentinel site was less than 1%. The seven zones of 
Surat City were merged into three evaluation unit (EUs) 
for effective administration of TAS as guided by WHO 
and national organizations [4, 18]. The central and east 
zone were considered as EU1; west, south-west and 
north zone as EU2; and south and south-east zone as 
EU3 (Fig. 1). The net primary school enrolment ratio of 
Surat City was 75.3%—near the recommended thresh-
old of 75%—therefore the school-based surveys strat-
egy was chosen [4, 18]. After selection of TAS strategy, a 
geographic list of all the city schools was prepared. Then, 
the WHO-recommended Survey Sample Builder (SSB) 
software was used for selecting clusters of schools, sam-
ple size, sampling fraction and interval from each school, 
along with pre-determined critical cut-off levels for the 
number of test positives, to ensure unbiased implemen-
tation and evaluation [4, 10, 18]. Only first- and second-
year primary-school going children (aged approximately 
6–7 years) were considered eligible to be participants for 
TAS because they have lived most of their lives through 
MDA and any infection in them indicates recent trans-
mission [4, 10, 18]. A total sample size of approximately 
seventeen hundred, and a critical cut-off limit of 20 FTS 
positives, were determined and achieved for each EU 
(Table 2). For TAS, Filarial Test Strips (FTS; Alere, Scar-
borough, ME, United States) were procured to detect 
filarial antigen  [23]. The TAS survey was conducted as 
a four-day long exercise from  3rd to  6th October 2016 
after training of PHWs and supporting staff of VBDC 
department.
All routine (NFCP/NVBDCP) and M&E (pre-MDA) 
surveys involved NBS collection by peripheral health 
workers  [4]. Briefly, a thick blood smear was prepared 
from a drop of approximately 20  mm3. The smears were 
Giemsa-stained and examined for microfilariae  [4, 20]. 
Quality assurance was maintained by cross-checking of 
all positive slides and 5% of negative slides by an inde-
pendent team of trained staff selected by the State Ento-
mologist. The NFCP staff was trained by SMC Insecticide 
Officer (IO) for conducting filaria surveys [24].
Table 1 Distribution of microfilaria (Mf )-positives in night blood slides (NBS) collected from sentinel and spot sites during pre-mass 
drug administration (MDA) surveys
Year Sentinel sites
Mf positive/ slides tested (Mf %)
Spot (random) sites
Sub jail / Siddharth 
Nagar (South Zone)







2008 3/512 (0.6) 8/568 (1.4) 13/516 (2.5) 16/509 (3.1) 40/2105 (1.9) 7/2079 (0.3)
2009 3/504 (0.6) 6/530 (1.1) 6/511 (1.2) 37/511 (7.2) 52/2056 (2.5) 9/2069 (0.4)
2010 2/502 (0.4) 5/548 (0.9) 6/519 (1.2) 23/503 (4.6) 36/2072 (1.7) 8/2727 (0.3)
2012 0/500 (0) 1/556 (0.2) 8/516 (1.6) 6/500 (1.2) 15/2072 (0.7) 0/2106 (0)
2014 8/504 (1.6) 2/525 (0.4) 3/516 (0.6) 4/503 (0.8) 17/2048 (0.8) 4/2104 (0.2)
2015 4/501 (0.8) 2/514 (0.4) 0/500 (0) 2/503 (0.4) 8/2018 (0.4) 4/2024 (0.2)
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A line-list of all Mf positive diagnosed in routine or 
pre-MDA survey was prepared and a detailed case inves-
tigation was conducted every year to explore their epide-
miological profile. Required investigations, treatments, 
health counselling and follow-up were done. A prede-
signed, pre-tested and semi-structured questionnaire was 
used to collect details including the length of stay at the 
present area of Surat City, native place of birth and his-
tory of visiting native place per year, although only for 
those Mf-positive. Residential conditions such as open 
sewage and drainage systems were described for micro-
filaremic individuals. The routine, pre-MDA and post-
MDA surveys were performed irrespective of migration 
status.
Study duration, design and participants
To summarize, epidemiological surveillance of infec-
tion and disease in the present study included routine 
filaria surveys, from 2008 to 2016, M&E (pre-MDA) sur-
veys from 2008 to 2015, and TAS in 2016. City residents 
except children less than 2  years, pregnant women and 
severely sick people formed the sampling frame for rou-
tine and pre-MDA survey while school-going children 
aged 6–7  years were selected for TAS. Regular supervi-
sion and monitoring was done by program supervisors 
and managers (Fig. 2). Various terms and indicators used 
in the study are summarized in the supplementary file for 
ready reference (Additional file 1).
People from all over Gujarat state (interstate) and other 
states of the country (intrastate) travel to Surat in search 
of jobs and business opportunities [15]. In order to meet 
the objective of identifying subgroups at higher residual 
risk of microfilaremia, NBS were analyzed according to 
place of birth captured as village (city), district and state 
of origin.
Study variables: The main outcomes were micro-
filaremia and antigen prevalence in people over the 
years 2008 to 2016. The explanatory variable of interest 
was place of birth i.e. whether or not born in Surat.
Data management and statistical methods
The PHW collected the data of filaria surveys on pre-
designed forms. This was supervised and consolidated 
to ward-level reports by field supervisors. These results 
were validated and entered into a Microsoft Excel file. 
Descriptive analysis was used to report and analyze 
survey findings; in particular, proportions with confi-
dence intervals. For the latter, to allow for clustering, 
the intracluster correlation coefficient (ICC) [25] of the 
proportion Mf-positive was calculated across sentinel 
sites for each year from 2008 to 2015. These ICCs were 
then used to estimate design effects to adjust confi-
dence intervals for the prevalence of Mf in humans (50 
wards per survey). Prevalence ratios, with confidence 
intervals and P  values, were calculated for migration 
status, aggregated over the period 2008–2015 inclusive, 
Table 2 Filarial test strips (FTS) findings among primary school children (6–7 years) of Surat City in transmission assessment survey 
(TAS) (2016)
a Of these 428 invalid tests, approximately 258 (60%) occurred on the first day (of four) of the TAS survey





Estimated number of 6–7 years children in EU 71 969 67 435 72 576
Total number of 6–7 years enrolled in schools 53 982 51 065 54 432
Total number of primary schools in EU 333 340 368
Average number of 6–7 year students per school 162 150 147
Sample size for cluster design 1692 1692 1692
Number of clusters 30 30 30
Sampling fraction 0.41 0.44 0.45
Sampling Interval 2.44 2.26 2.21
Critical cut off 20 20 20
Total FTS done 1850 1865 1849
Total FTS positive 6 10 12
FTS positive born outside Surat 5 10 11
FTS positive in areas with poor sanitation 6 out of 6 10 out of 10 12 out of 12
Total FTS negative 1691 1715 1702
FTS  invalida 153 140 135
Antigenemia % 0.35 0.58 0.7
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separately for routine and pre-MDA surveys. For this, 
the method of Katz et al. [26] was used, with the stand-
ard error of the logarithm of the prevalence ratio again 
being inflated via the design effect, taken to be the 
average of the above year-specific design effects for 
this period. The R software, version 3.6.3, was used (R 
Foundation for Statistical Computing, Vienna, Austria).
Results
Routine (NFCP) surveys
During the routine surveys, conducted by PHWs between 
2008 and 2016 in Surat City, a total of 306 198 NBS (mean 
34 021 per year) were examined; of which 353 NBS were 
Mf-positive (mean 39 per year). This proportion declined 
from 63/18 814 (0.33%) in 2008 to 23/39 717 (0.06%) in 
2016 (Additional file 2). Over the same period, of 306 198 
examined, 375 (0.12%) were found to have filarial disease, 
decreasing from 106/18 814 (0.56%) in 2008 to 20/39 717 
(0.05%) in 2016 (Additional file 4).
Monitoring and evaluation (pre-MDA surveys)
The pre-MDA surveys covered approximately 4000 pop-
ulation from four sentinel and four random/spot sites 
once a year. Between 2008 and 2015 a total of 25 480 pre-
MDA NBS (mean 4247; range: 4042–4799) were exam-
ined with 200 Mf-positive. This proportion declined from 
47/4184 (1.1%) in 2008 to 12/4042 (0.3%) in 2015 (Table 1 
and Additional file  3). Since the beginning of MDA 
rounds and selection of sites for survey, the sentinel sites 
had a higher Mf prevalence compared to random sites 
selected from other city areas. Among the four sentinel 
sites, Ashok Nagar had the highest Mf prevalence which 
declined from 3.1% in 2008 to 0.4% in 2015.
Sub-group analysis of microfilaremia prevalence
All microfilaremic persons were contacted and line-listed 
for health advice, home-visits, treatment, adherence, and 
follow-ups. Out of 306 198 NBS from routine surveys, 
224 415 were from those born outside the city (migrants) 
and 81 783 (24%) from those born in Surat. Of these, 
318 (0.14%) and 35 (0.043%), respectively, were micro-
filaremic (Figs. 3 and 4): a prevalence ratio of 3.31 [95% 
confidence interval (CI) 1.47–7.48, P = 0.004]. Although 
data on living conditions were not systematically col-
lected, positive patients generally lived in highly crowded 
areas with open drainage systems.
Corresponding results from the pre-MDA surveys 
show that out of 25 480 slides examined, 18 050 (71%) 
were from people born outside Surat and the rest 7430 
(29%) were from people born in Surat City (Fig.  5). 
Among these, 177 (0.98%) and 23 (0.31%) respectively 
were microfilaremic; a prevalence ratio of 3.17 (95% CI: 
1.15–8.72; P = 0.026).
TAS or post MDA assessment
In the TAS survey, among school-going children aged 
6–7 years, a total of 5564 Filariasis Test Strips (FTS) were 
performed with six, ten and twelve positive in the three 
EUs respectively (Table 2). The numbers positive were all 
less than 20 (the pre-determined cut-off value) in each 
EU. Of the 28 FTS-positive children, 26 (92%) were not 
born in Surat (Table  2), and reported returning to visit 
Fig. 2 Timeline of the different surveys for elimination of lymphatic filariasis in Surat. WHO collaborative Global Programme to Eliminate Lymphatic 
Filariasis (GPELF) was adopted in India in 1996 and expanded to involve Surat City in 2004. MDA Mass Drug Administration, TAS Transmission 
Assessment Survey
Page 7 of 10Modi et al. Infect Dis Poverty           (2021) 10:73  
their place of birth at least once a year. Consistent with 
the above observations, all microfilaremic children were 
inhabitants of areas with places conducive to Culex vec-
tor breeding.
Discussion
A review of literature shows that studies on ELF and 
implementation of MDA are very few in large urban 
areas of India [27] and other endemic parts of the 
world [1, 14, 28]. The present study describes the MDA 
program in Surat, a resource-constrained developing 
country setting, where the challenging task of admin-
istering at least 4.5 million treatments (every year for 
12 rounds) was undertaken ensuring adequate coverage 
and compliance [19, 20]. The pre-MDA surveys show 
that the Mf rate declined by 74% (1.1% in year 2008 and 
0.3% in 2015) in Surat City [20]. The routine/NVBDCP 
surveys indicated a similar decline of 82.7% (0.33% in 
year 2008 to 0.06% in 2016). These sustained reduc-
tions in microfilaremia indicate that MDA has helped 
to eliminate filariasis from urban areas of Surat and is 
in accordance with ELF program results in other coun-
tries [1, 9].
After successful MDA rounds, an essential challenge 
to the Global Programme’s success in combating LF is 
deciding the stopping points for MDA  [29]. The WHO 
recommends TAS surveys to diagnose and determine 
antigenemia in 6–7 year old children assuming that any 
infection in these children will detect community trans-
mission in presence of annual mass chemotherapy [4, 
10]. In the present study, TAS was conducted with FTS 
among 1650, 1685 and 1649 (total 5564) children to get 
an antigenemia prevalence of 0.35, 0.58 and 0.7% in the 
three EUs respectively (overall 0.54%). Though these 
results were below the pre-decided target threshold of 
2% antigenemia, and established endpoints for MDA in 
Surat, further sub-group analysis revealed that ninety 
percent of antigenemic children were from families of 
populations born outside Surat City and having history 
of visiting native endemic areas (Table 2). These findings 
implicate existence of “hidden hot-spots” [11] or residual 
microfilaremia not detectable by existing recommended 
GPELF programmatic monitoring.
All positive patients were visited in the field to ensure 
treatment compliance and it was observed that the liv-
ing conditions of microfilaremic people, whether born in 
Surat or not, had poor sanitation and hygiene, e.g. open 
drains, favoring the Culex vector. Simonsen et al. found 
similar focality in less privileged city populations in his 
review (2013) of major studies on urban filariasis [3]. Pre-
vious findings suggest that even small areas omitted from 
control programs have the potential to serve as dispersal 
foci for filariasis including urban areas [13, 14] especially 
in context of efficient parasite-vector combinations [3].
The MDA achievements in South Gujarat, documented 
here and elsewhere [12, 19, 20], are tempered by indica-
tions that the ‘residual microfilarial infection phase’ or a 
relatively higher Mf prevalence may exist in certain areas 
or populations, possibly including those with higher rates 
of inward migration from endemic areas [14]. On further 
sub-group analysis of the NBS survey results in the pre-
sent study, it was observed that annual chemotherapy has 
succeeded in maintaining decreases in microfilaremia 
prevalence (Mf rate) in the whole city population, and 
below 1% in almost all subgroups. However, the preva-
lence in people born outside Surat or having history of 
visiting/residing filariasis endemic areas remains treble 
that of other people (Fig. 3). Populations from relatively 
Fig. 3 Prevalence of microfilaremia over time according to place of birth: in Surat or elsewhere (migrants). The prevalence of microfilaremia (Mf % 
or Mf rate) was calculated as the percentage of persons showing microfilaria in their peripheral blood (night blood smears)
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high-endemicity northern and eastern states of country 
were most likely to be microfilaremic (Figs.  4, 5). Some 
other studies have found similar associations [3, 13, 14, 
30] though none has conducted long term comprehen-
sive follow-up of a large city population, both before and 
after MDA, as reported here. Research in Thailand and 
the Andaman Islands similarly showed the potential for 
migration to establish transmission [16, 31]. However, 
in Sierra Leone and Liberia, filariasis does not seem to 
have been established by mass migration from rural to 
urban areas. On the other hand, in these areas the para-
site would need to adapt from Anopheles to Culex vec-
tors  [28], a hurdle which does not exist in India where 
Cx quinquefasciatus is the vector of W. bancrofti. It is 
Fig. 4 Stacked bar chart of numbers of microfilaremic individuals by state of birth, from the routine surveys in Surat, 2008–16. For example, in 2008, 
night blood smears from 7,189 individuals born in Orissa were tested for microfilaria, of which 41 were Mf positive
Fig. 5 Stacked bar chart of numbers of microfilaremic individuals by state of birth, from the pre-MDA surveys in Surat, 2008–2015. For example, in 
2008, night blood smears from 420 individuals born in Orissa were tested for microfilaria, of whom 27 were Mf positive
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possible that the potential for onward transmission is 
reduced by their living among people from other parts 
of the country, with lower prevalence. This reinforces the 
need for continued vigilance and, in particular to develop 
and maintain a “comprehensive residual microfilaremic 
sensitive” urban LF surveillance  [1, 12, 15] including 
entomological surveillance  [5] and MDA as appropri-
ate [16]. A systematic review of 42 studies on health and 
healthcare in India suggests that internal migrants should 
be considered as vulnerable and specific populations in 
need of targeted interventions by health systems  [15]. 
We recommend that future research on LF should target 
on identifying and surveying vulnerable populations in 
urban areas.
There were several limitations to the present study. 
Although there was an association between micro-
filaremia and birth outside Surat, we cannot say with 
certainty where filarial infections were acquired. In other 
words, risk of infection within Surat may differ between 
those born in the city or elsewhere. Another limitation 
is that health workers are responsible for executing mul-
tiple programs during the same field work shifts, which 
can result in collection of routine NBS at infrequent 
intervals. Moreover, we have been able to present trend 
analysis for whole city rather than analysis by site (except 
sentinel sites of pre-MDA). The surveillance guidance for 
each program remained constant throughout the period 
reported here. Overall, this is a strength as the routine/
NVBDCP surveys aimed to explore different city popula-
tions and areas each year to identify “hot-spots of resid-
ual microfilaremia” while pre-MDA surveys focused on 
sentinel sites to monitor the impact of MDA program. 
However, for those programs, in particular the routine 
surveys, which covers one decade, the guidance appro-
priate at the start of the period may have reduced appli-
cability to the current city, which has changed greatly in 
terms of culture, demography and sheer size after year 
2009 (https:// www. surat munic ipal. gov. in/ TheCi ty/ City/ 
Stml1).
Conclusions
These extensive epidemiological studies of urban fila-
riasis suggest that urban populations including vulner-
able groups like internal migrants have benefited from 
programmatic drug treatment and monitoring. It also 
confirms the global concerns that the overall living con-
ditions and mobility makes people susceptible to higher 
microfilaremia levels than other populations. We con-
clude and recommend that after achieving end-points 
of MDA in large urban areas, ELF programs develop 
customized “comprehensive residual microfilaremic 
sensitive” strategies to prioritize existing resources 
on surveillance and treatment of vulnerable groups 
living in areas with effective host vector relationship, 
for these populations’ own benefit and to prevent resur-
gence in the wider population. The present research 
can be used as an example to frame strategies to this 
effect. We also endorse previous findings on the need 
for guidelines on monitoring migration, with the aim 
of increasing migrants’ treatment coverage. Standard 
or WHO recommendations in this regard could further 
the important goal of maintaining the original gains 
and preventing re-infection and transmission in high-
risk populations; as well as provide an added benefit 
of enrolment of migrants into the existing health care 
system.
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